Abstract
Address: 1Medical Affairs, International AIDS Vaccine Initiative, San Francisco, CA, USA, 2Emory University, Atlanta, GA, USA, 3Kenyan AIDS Vaccine Initiative, Nairobi, Kenya, 4University of Cape Town, Desmond Tutu HIV Foundation, Cape Town, South Africa, 5MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda, 6Rwanda Zambia HIV Research Group, Kigali, Rwanda, 7Aurum Institute for Health Research, Rustenburg, South Africa and 8Kenyan Medical Research Institute, Kilifi, Kenya * Corresponding author
Highlights
Africa is a crucial setting for preventive HIV clinical trials
We present our experience of setting up a collaborative network of African clinical research centers (CRC)
The populations vary by CRC and include HIV-discordant couples, commercial sex workers, and men who have sex with men
Summary
Africa is a crucial setting for preventive HIV clinical trials. We present our experience of setting up a collaborative network of African clinical research centers (CRC). Building an African HIV preventive trial network Address: 1Medical Affairs, International AIDS Vaccine Initiative, San Francisco, CA, USA, 2Emory University, Atlanta, GA, USA, 3Kenyan AIDS Vaccine Initiative, Nairobi, Kenya, 4University of Cape Town, Desmond Tutu HIV Foundation, Cape Town, South Africa, 5MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda, 6Rwanda Zambia HIV Research Group, Kigali, Rwanda, 7Aurum Institute for Health Research, Rustenburg, South Africa and 8Kenyan Medical Research Institute, Kilifi, Kenya * Corresponding author from AIDS Vaccine 2009 Paris, France.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
